Imuran Dosing in Crohn's Disease Study

NCT00113503 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

50

Enrollment

NIH

Sponsor class

Stopped Insufficient enrollment

Conditions

Crohn's Disease

Interventions

DRUG: Azathioprine weight-based dose
DRUG: Azathioprine individualised dose

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborators

[object Object]